跳至主導覽
跳至搜尋
跳過主要內容
澳門理工大學 首頁
English
中文
首頁
研究單位
研究成果
學術履歷
新聞/媒體
按專業知識、姓名或所屬機構搜尋
連絡專家
查看斯高帕斯 (Scopus) 概要
孟 麗榮
Professor
Professor
,
Faculty of Health Sciences and Sports
電話
85993449
電子郵件
lrmeng
mpu.edu
mo
h-index
683
引文
17
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
2004
2025
每年研究成果
概覽
指紋
網路
研究成果
(56)
新聞/媒體
(1)
類似的個人檔案
(6)
指紋
查看啟用 LI RONG MENG 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Endometrium Cancer
100%
Neoplasm
63%
Small Interfering RNA
60%
Endometrium Carcinoma
58%
Ovary Carcinoma
58%
Messenger RNA
51%
Paclitaxel
44%
Nude Mouse
33%
Chemotherapy
31%
Epidermal Growth Factor Receptor 2
31%
Cordycepin
29%
Clotrimazole
29%
Prevalence
29%
Gamma Urogastrone
29%
Bladder Cancer
29%
Phytochemical
29%
Candida Albicans
29%
Ovary Cancer
23%
Cisplatin
22%
Carcinoma
21%
Malignant Neoplasm
19%
Tumor Model
18%
Tumor Suppressor Protein
18%
Rapamycin
16%
Survivin
16%
Traditional Chinese Medicine
14%
Long Untranslated RNA
14%
Epidermal Growth Factor Receptor
14%
Mammalian Target of Rapamycin
14%
Metastasis Potential
14%
Sorafenib
14%
Tyrphostin
14%
Enterovirus A71
14%
Hernandesine
14%
Liver Cell Carcinoma
14%
Complementary RNA
14%
Rosiglitazone
14%
microRNA 24
14%
Growth Factor Receptor
14%
Coptis Chinensis
14%
Sleep Disorder
14%
Viral Protein
14%
Phosphotransferase Inhibitor
14%
Hedyotis
14%
Synergism
14%
Antifungal Activity
14%
Helicobacter Pylori
14%
Antibiotics
14%
Tumor Invasion
14%
microRNA 125b
14%
Biochemistry, Genetics and Molecular Biology
Small Interfering RNA
58%
Cordycepin
44%
Cell Invasion
42%
Cancer Cell
36%
Cisplatin
36%
Transfection
33%
down Regulation
30%
Extracellular Signal-Regulated Kinases
29%
MicroRNA
29%
Signal Transduction
24%
Messenger RNA
22%
Wart Virus
19%
RNAI
17%
XIAP
17%
Western Blotting
16%
Chemosensitivity
15%
Passive Smoking
14%
Enhancer Region
14%
2,5-Dimethoxy-4-iodoamphetamine
14%
Epidermal Growth Factor Receptor
14%
Deep Sequencing
14%
Transcription
14%
U0126
14%
Methicillin Resistant Staphylococcus Aureus
14%
Notch
14%
Extract
14%
Sensitive Detection
14%
Protospacer Adjacent Motif
14%
Human Papillomavirus Type 16
14%
K Cl- Cotransporter
14%
Long Non-Coding RNA
14%
Orthology
14%
Cell Proliferation
12%
Insulin-Like Growth Factor 1
12%
Genome Editing
9%
CRISPR
9%
Glyceraldehyde 3-Phosphate Dehydrogenase
9%
Real-Time Polymerase Chain Reaction
9%
Flow Cytometry
7%
Malignant Transformation
7%
Biological Phenomena and Functions Concerning the Entire Organism
7%
Cell Membrane
7%
RNA Sequence
7%
Gene Ontology
7%
Gene Mutation
7%
Mammalian Target of Rapamycin
7%
Biological Functions
7%
Transcription Factor EZH2
7%
Lipid Metabolism
7%
Promoter Region
7%
Medicine and Dentistry
Uterine Cancer
48%
Cell Line
30%
Endometrium Carcinoma
29%
Small Interfering RNA
29%
Krukenberg Tumor
29%
Carcinoma Cell
29%
Neoplasm
27%
RNAI
23%
Programmed Cell Death
23%
Genetic Transfection
20%
Cancer Cell
20%
Cell Invasion
18%
Epidermal Growth Factor Receptor 2
16%
Signal Transduction
14%
Mitogen-Activated Protein Kinase
14%
Paclitaxel
14%
Long Untranslated RNA
14%
Tumor Model
14%
Complementary RNA
14%
Kinase Signaling
14%
Gamma Urogastrone
14%
Metastasis Potential
14%
Gestational Diabetes
14%
First Trimester Pregnancy
14%
Assisted Reproductive Technology
14%
Cross Sectional Study
14%
Physical Activity
14%
Growth Factor Receptor
14%
Bioluminescence
14%
Cordycepin
14%
Tumor Suppressor Protein
14%
Endoscopic Mucosal Resection
14%
Colorectal Polyp
14%
Cold Snare Polypectomy
14%
Immune Checkpoint Inhibitor
14%
Immune-Related Adverse Events
14%
Child Health
14%
Mental Stress
14%
Perinatal Period
14%
Messenger RNA
13%
Somatomedin C
12%
Tumor Cell
12%
Metastatic Carcinoma
11%
Mitogen Activated Protein Kinase 3
9%
Western Blotting
9%
Transfected Cell Line
8%
Gelatinase B
8%
Cancer Stem Cell
8%
Surgery
8%
Janus Kinase 1
7%